Related Experiment Video
Updated: Mar 28, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Targeting the Hippo pathway: Clinical implications and therapeutics
Shuai Ye1, T S Karin Eisinger-Mathason1
1Abramson Family Cancer Research Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Philadelphia, PA, USA; University of Pennsylvania Sarcoma Program, Philadelphia, PA, USA.
The Hippo pathway regulates organ size by controlling cell growth and death. Its dysfunction is linked to cancers, suggesting Hippo pathway proteins are potential therapeutic targets.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The Hippo pathway is a crucial regulator of tissue and organ size.
- It maintains homeostasis by controlling cell proliferation and apoptosis.
- Aberrant Hippo pathway signaling is implicated in tumorigenesis.
Purpose of the Study:
- To review the current understanding of Hippo pathway function.
- To elucidate the role of the Hippo pathway in human cancers.
- To explore the potential of Hippo pathway proteins as cancer therapeutic targets.
Main Methods:
- Literature review of Hippo pathway research.
- Analysis of Hippo pathway's role in various cancer types.
- Evaluation of therapeutic strategies targeting the Hippo pathway.
Main Results:
- The Hippo pathway's intricate mechanisms in regulating cell fate.
- Evidence linking Hippo pathway deregulation to sarcoma, breast, lung, and liver cancers.
- Identification of key Hippo pathway proteins with therapeutic potential.
Conclusions:
- The Hippo pathway is a critical regulator of organ size and a key player in cancer development.
- Targeting Hippo pathway components offers a promising avenue for novel cancer therapies.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Hedgehog Signaling Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

